Cargando…
Comparison of low-density lipoprotein cholesterol equations in patients with dyslipidaemia receiving cholesterol ester transfer protein inhibition
AIMS: Low-density lipoprotein (LDL-C) lowering is imperative in cardiovascular disease prevention. We aimed to compare accuracy of three clinically-implemented LDL-C equations in a clinical trial of cholesterol ester transfer protein (CETP) inhibition. METHODS AND RESULTS: Men and women aged 18–75 y...
Autores principales: | Martin, Seth S, Ditmarsch, Marc, Simmons, Mark, Alp, Nicholas, Turner, Traci, Davidson, Michael H, Kastelein, John J P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9892865/ https://www.ncbi.nlm.nih.gov/pubmed/36307922 http://dx.doi.org/10.1093/ehjcvp/pvac056 |
Ejemplares similares
-
Cholesteryl ester transfer protein inhibitors: from high-density lipoprotein cholesterol to low-density lipoprotein cholesterol lowering agents?
por: Nurmohamed, Nick S, et al.
Publicado: (2021) -
Validation of low-density lipoprotein cholesterol equations in pediatric population
por: Ertürk Zararsız, Gözde, et al.
Publicado: (2023) -
Achievement of Low-Density Lipoprotein Cholesterol Targets in Cardiac Rehabilitation: Impact of the 2019 ESC/EAS Dyslipidaemia Guidelines
por: Haegele, Matthias, et al.
Publicado: (2022) -
Assessing the Accuracy of Estimated Lipoprotein(a) Cholesterol and Lipoprotein(a)‐Free Low‐Density Lipoprotein Cholesterol
por: Zheng, Weili, et al.
Publicado: (2022) -
The Impact of Low-Density Lipoprotein Equation Changes on Cholesterol Treatment in Canada
por: Zhao, Pei Jun, et al.
Publicado: (2022)